MTOR and lung disorder: In summary, pharmacologic mTOR pathway inhibition attenuates hypercapnia-induced autophagy arrest in satellite cells and dysfunctional myogenesis, which could be relevant to improve clinical outcomes of patients with muscle wasting in CO2-retaining pulmonary diseases.